Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun/CCL22 signal

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 11, 2015, Pages 2494-2503

  Liang, Ding ^a   Xiao Feng, Huang ^a   Guan Jun, Dong ^a   Er Ling, Hu ^a   Sheng, Chen ^a   Ting Ting, Wang ^a   Qin Gang, Hu ^a   Yan Hong, Ni ^a   Ya Yi, Hou ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

C jun; HPV; MiR 27; STING; Tregs

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BETA INTERFERON; FAS ANTIGEN; GELATINASE B; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1; MICRORNA; MICRORNA 124; MICRORNA 27; MICRORNA 27B; MICRORNA 34C; MICRORNA 449B; MIDKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; PROTEIN P16; SMALL INTERFERING RNA; STIMULATOR OF INTERFERON GENE PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTIC INFILTRATION; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA CELL LINE; STAINING; TONGUE CARCINOMA; UPREGULATION; WART VIRUS;

EID: 84941057753     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.08.011     Document Type: Article

References (38)

1. Ishikawa H., Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455(7213):674-678.
2. Abe T., Harashima A., Xia T., Konno H., Konno K., Morales A., et al. STING recognition of cytoplasmic DNA instigates cellular defense. Mol. Cell 2013, 50(1):5-15.
3. Gao P., Ascano M., Wu Y., Barchet W., Gaffney B.L., Zillinger T., et al. Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 2013, 153(5):1094-1107.
4. Ahn J., Xia T., Konno H., Konno K., Ruiz P., Barber G.N. Inflammation-driven carcinogenesis is mediated through STING. Nat. Commun. 2014, 5:5166.
5. Saitoh T., Fujita N., Hayashi T., Takahara K., Satoh T., Lee H., et al. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(49):20842-20846.
6. Liu Y., Jesus A.A., Marrero B., Yang D., Ramsey S.E., Montealegre Sanchez G.A., et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 2014, 371(6):507-518.
7. Sharma S., Campbell A.M., Chan J., Schattgen S.A., Orlowski G.M., Nayar R., et al. Suppression of systemic autoimmunity by the innate immune adaptor STING. Proc. Natl. Acad. Sci. U. S. A. 2015, 112(7):E710-717.
8. Downey C.M., Aghaei M., Schwendener R.A., Jirik F.R. DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization. PLoS One 2014, 9(6).
9. Zhu Q., Man S.M., Gurung P., Liu Z., Vogel P., Lamkanfi M., et al. Cutting edge: STING mediates protection against colorectal tumorigenesis by governing the magnitude of intestinal inflammation. J. Immunol. 2014, 193(10):4779-4782.
10. Lemos H., Huang L., Chandler P.R., Mohamed E., Souza G.R., Li L., et al. Activation of the STING adaptor attenuates experimental autoimmune encephalitis. J. Immunol. 2014, 192(12):5571-5578.
11. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324(1):17-27.
12. Flores E.R., Allen-Hoffmann B.L., Lee D., Sattler C.A., Lambert P.F. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology 1999, 262(2):344-354.
13. Williams R., Lee D.W., Elzey B.D., Anderson M.E., Hostager B.S., Lee J.H. Preclinical models of HPV+ and HPV- HNSCC in mice: an immune clearance of HPV+ HNSCC. Head Neck 2009, 31(7):911-918.
14. Nasman A., Romanitan M., Nordfors C., Grun N., Johansson H., Hammarstedt L., et al. Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One 2012, 7(6).
15. Badoual C., Hans S., Merillon N., Van Ryswick C., Ravel P., Benhamouda N., et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res. 2013, 73(1):128-138.
16. Jaafar F., Righi E., Lindstrom V., Linton C., Nohadani M., Van Noorden S., et al. Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer. Am. J. Pathol. 2009, 175(4):1525-1535.
17. Scott M.E., Ma Y., Kuzmich L., Moscicki A.B. Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3. Int. J. Cancer 2009, 124(6):1379-1383.
18. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 2014, 64(1):9-29.
19. Remmink A.J., Walboomers J.M., Helmerhorst T.J., Voorhorst F.J., Rozendaal L., Risse E.K., et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36months. International journal of cancer Journal international du cancer 1995, 61(3):306-311.
20. Sun W., Li Y., Chen L., Chen H., You F., Zhou X., et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(21):8653-8658.
21. Sunthamala N., Thierry F., Teissier S., Pientong C., Kongyingyoes B., Tangsiriwatthana T., et al. E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-kappa transcription in keratinocytes. PLoS One 2014, 9(3).
22. McBride A.A. The papillomavirus E2 proteins. Virology 2013, 445(1-2):57-79.
23. Abe T., Harashima A., Xia T., Konno H., Konno K., Morales A., et al. STING recognition of cytoplasmic DNA instigates cellular defense. Molecular cell. 2013, 50(1):5-15.
24. Petrasek J., Iracheta-Vellve A., Csak T., Satishchandran A., Kodys K., Kurt-Jones E.A., et al. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(41):16544-16549.
25. Bhatelia K., Singh A., Tomar D., Singh K., Sripada L., Chagtoo M., et al. Antiviral signaling protein MITA acts as a tumor suppressor in breast cancer by regulating NF-kappaB induced cell death. Biochim. Biophys. Acta 2014, 1842(2):144-153.
26. Chang F., Syrjanen S., Tervahauta A., Kurvinen K., Wang L., Syrjanen K. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. Br. J. Cancer 1994, 70(2):346-351.
27. Menetrier-Caux C., Gobert M., Caux C. Differences in tumor regulatory T-cell localization and activation status impact patient outcome. Cancer Res. 2009, 69(20):7895-7898.
28. Brandacher G., Perathoner A., Ladurner R., Schneeberger S., Obrist P., Winkler C., et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin. Cancer Res. 2006, 12(4):1144-1151.
29. Zhao S., Wang H., Nie Y., Mi Q., Chen X., Hou Y. Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity. Cancer Immunol. Immunother. 2012, 61(10):1745-1753.
30. Chen H., Sun H., You F., Sun W., Zhou X., Chen L., et al. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 2011, 147(2):436-446.
31. Shaulian E. AP-1-The Jun proteins: oncogenes or tumor suppressors in disguise?. Cell. Signal. 2010, 22(6):894-899.
32. Lee Y.S., Dutta A. MicroRNAs in cancer. Annu. Rev. Pathol. 2009, 4:199-227.
33. Lam A.R., Le Bert N., Ho S.S., Shen Y.J., Tang M.L., Xiong G.M., et al. RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma. Cancer Res. 2014, 74(8):2193-2203.
34. Klarquist J., Hennies C.M., Lehn M.A., Reboulet R.A., Feau S., Janssen E.M. STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells. J. Immunol. 2014, 193(12):6124-6134.
35. Huang L., Li L., Lemos H., Chandler P.R., Pacholczyk G., Baban B., et al. Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses. J. Immunol. 2013, 191(7):3509-3513.
36. Eferl R., Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 2003, 3(11):859-868.
37. Young M.R., Li J.J., Rincon M., Flavell R.A., Sathyanarayana B.K., Hunziker R., et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(17):9827-9832.
38. Li X.D., Wu J., Gao D., Wang H., Sun L., Chen Z.J. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 2013, 341(6152):1390-1394.